SAFETY AND EFFICACY OF TISAGENLECLEUCEL PLUS PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: UPDATED ANALYSIS OF THE PHASE 1B PORTIA STUDY

Authors :: Ulrich Jaeger
Marcela Martinez-Prieto
Peter Borchmann
Peter A. Riedell
Isabelle Fleury
Nina Worel
Ahmed M. Abdelhady
Edmund K. Waller
Y. Du
Joseph P. McGuirk
Xia Han
Source :: Hematological Oncology. 39
Publication Year :: 2021
Publisher :: Wiley, 2021.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
Hematology
General Medicine
Pembrolizumab
medicine.disease
Internal medicine
Relapsed refractory
medicine
In patient
business
Diffuse large B-cell lymphoma

Tools